Carriage of multidrug-resistant Gram-negative bacilli: duration and risk factors.
Carriage
ESBL
KPC
MDR
OXA48
Pseudomonas aeruginosa
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
24
11
2022
accepted:
24
02
2023
medline:
18
4
2023
pubmed:
26
3
2023
entrez:
25
3
2023
Statut:
ppublish
Résumé
Identification of risk factors influencing the duration of carriage of multidrug-resistant Gram-negative bacilli (MDR-GNB) may be useful for infection control. The aim of this study is to estimate the impact of several factors collected for routine hospital surveillance on the duration of carriage of selected MDR-GNB. From January 2015 to July 2021, patients with at least two clinical/surveillance samples positive for MDR-GNB different from ESBL-producing E. coli or AmpC - exclusively producing Enterobacterales were assessed. Microorganisms, age, number of admissions, clinical or rectal sample, sex, and admission service were evaluated as risk factors. Multivariate analysis was performed by a Cox proportional hazard model. A total of 1981 episodes of colonization were included. Involved microorganisms were ESBL-Klebsiella pneumoniae (KP) in 1057 cases (53.4%), other ESBL-non-E. coli Enterobacterales in 91 (4.6%), OXA-48-KP in 263 (13.3%), KPC-KP in 90 (4.5%), VIM-KP in 29 (1.5%), carbapenemase-producing non-KP Enterobacterales (CP-non-KP) in 124 (6.3%), and MDR Pseudomonas aeruginosa (MDR-PAER) in 327 (16.5%). No differences in duration of colonization were observed among ESBL-KP (median colonization time 320 days), ESBL-non-E. coli Enterobacterales (226 days), OXA48-KP (305 days), and MDR-PAER (321 days). For each group, duration of colonization was significantly longer than that of KPC-KP (median colonization time 60 days), VIM-KP (138 days), and CP-non-KP (71 days). Male sex (HR = 0.88; 95% CI 0.78-0.99), detection in Hepatology-Gastroenterology (HR = 0.71; 95% CI 0.54-0.93), clinical sample (HR = 0.61; 95% CI 0.53-0.69), and > 2 admissions after first detection (HR = 0.47; 95% CI 0.42-0.52) were independent predictors of longer carriage, whereas VIM-KP (HR = 1.61; 95% CI 1.04-2.48), KPC-KP (HR = 1.85; 95% CI 1.49-2.3), and CP-non-KP (HR = 1.92; 95% CI 1.49-2.47) were associated with shorter colonization time. Duration of colonization was significantly longer for ESBL-KP, other ESBL-non-E. coli Enterobacterales, OXA-48-KP, and MDR-PAER. For these microorganisms, prolonging surveillance up to 2.5-3 years should be considered. Male sex, clinical sample, multiple readmissions, admission service, and type of microorganism are independent predictors of the duration of carriage.
Identifiants
pubmed: 36964885
doi: 10.1007/s10096-023-04581-1
pii: 10.1007/s10096-023-04581-1
doi:
Substances chimiques
beta-Lactamases
EC 3.5.2.6
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
631-638Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Yamamoto M, Pop-Vicas AE (2014) Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have? Crit Care 18(3):229. https://doi.org/10.1186/cc13949
doi: 10.1186/cc13949
pubmed: 25041592
pmcid: 4075344
Morrill HJ, Pogue JM, Kaye KS, LaPlante KL (2015) Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis 2(2). https://doi.org/10.1093/ofid/ofv050 .
Engler-Hüsch S, Heister T, Mutters NT, Wolff J, Kaier K (2018) In-hospital costs of community-acquired colonization with multidrug-resistant organisms at a German teaching hospital. BMC Health Serv Res 18:737. https://doi.org/10.1186/s12913-018-3549-0
doi: 10.1186/s12913-018-3549-0
pubmed: 30257671
pmcid: 6158851
Woerther PL, Burdet C, Chachaty E, Andremont A (2013) Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 26:744–758. https://doi.org/10.1128/CMR.00023-13
doi: 10.1128/CMR.00023-13
pubmed: 24092853
pmcid: 3811232
Nicolas-chanoine MH, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Bert F et al (2013) 10-fold increase (2006–11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a parisian check-up centre. J Antimicrob Chemother 68:562–568. https://doi.org/10.1093/jac/dks429
doi: 10.1093/jac/dks429
pubmed: 23143897
Kim J, Lee JY, Kim S, Song W, Kim JS, Jung S et al (2014) Rates of fecal transmission of extended-spectrum ß-lactamase- producing and carbapenem-resistant enterobacteriaceae among patients in intensive care units in Korea. Ann Lab Med 34:20–25. https://doi.org/10.3343/alm.2014.34.1.20
doi: 10.3343/alm.2014.34.1.20
pubmed: 24422191
Prevel R, Boyer A, M’Zali F, Cockenpot T, Lasheras A, Dubois V, et al (2019) Extended spectrum beta-lactamase producing Enterobacterales faecal carriage in a medical intensive care unit: low rates of cross-transmission and infection. Antimicrob Resist Infect Control 8(1). https://doi.org/10.1186/s13756-019-0572-9 .
Swaminathan M, Sharma S, Blash SP, Patel G, Banach DB, Phillips M et al (2013) Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 34:809–817. https://doi.org/10.1086/671270
doi: 10.1086/671270
pubmed: 23838221
Bhargava A, Hayakawa K, Silverman E, Haider S, Alluri KC, Datla S et al (2014) Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients: exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 35:398–405. https://doi.org/10.1086/675614
doi: 10.1086/675614
pubmed: 24602945
Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B (2014) Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control 42(5):e61–e64. https://doi.org/10.1016/j.ajic.2014.01.024
doi: 10.1016/j.ajic.2014.01.024
pubmed: 24773806
Day KM, Ali S, Mirza IA, Sidjabat HE, Silvey A, Lanyon CV et al (2013) Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. Diagn Microbiol Infect Dis 75:187–191. https://doi.org/10.1016/j.diagmicrobio.2012.11.006
doi: 10.1016/j.diagmicrobio.2012.11.006
pubmed: 23246367
Bar-Yoseph H, Hussein K, Braun E, Paul M (2016) Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. J Antimicrob Chemother 71:2729–2739. https://doi.org/10.1093/jac/dkw221
doi: 10.1093/jac/dkw221
pubmed: 27317444
Zimmerman FS, Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y (2013) Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control 41:190–194. https://doi.org/10.1016/j.ajic.2012.09.020
doi: 10.1016/j.ajic.2012.09.020
pubmed: 23449280
de Smet AM, Kluytmans JA, Blok HE, Mascini EM, Benus RF, Bernards AT et al (2010) Effects of selective digestive and selective oropharyngeal decontamination on bacteraemia and respiratory tract colonization with highly resistant micro-organisms. Clin Microbiol Infect 16:S98
Cooper BS, Mascini EM, Werf TS Van Der, Hoeven JG Van Der, Pickkers P, Bernards AT, et al (2015) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 1;360
Daneman N, Sarwar S, Fowler RA, Cuthbertson BH (2013) Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 13:328–341. https://doi.org/10.1016/S1473-3099(12)70322-5
doi: 10.1016/S1473-3099(12)70322-5
pubmed: 23352693
Wittekamp BH, Plantinga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J et al (2018) Decontamination strategies and bloodstream infections with antibiotic-resistant microorganisms in ventilated patients: a randomized clinical trial. JAMA - J Am Med Assoc 320:2087–2098. https://doi.org/10.1001/jama.2018.13765
doi: 10.1001/jama.2018.13765
SuDDICU Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group, Myburgh JA, Seppelt IM, Goodman F, Billot L, Correa M, et al (2022) Effect of selective decontamination of the digestive tract on hospital mortality in critically ill patients receiving mechanical ventilation: a randomized clinical trial. https://doi.org/10.1001/jama.2022.17927 .
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
doi: 10.1111/j.1469-0691.2011.03570.x
pubmed: 21793988
Cervera C, van Delden C, Gavaldà J, Welte T, Akova M, Carratalà J (2014) Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect 20:49–73. https://doi.org/10.1111/1469-0691.12687
doi: 10.1111/1469-0691.12687
pubmed: 24861521
Alevizakos M, Kallias A, Flokas ME, Mylonakis E (2017) Colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae in solid organ transplantation: a meta-analysis and review. Transpl Infect Dis 19(4):e12718. https://doi.org/10.1111/tid.12718
doi: 10.1111/tid.12718
Ferst PG, Filmann N, Heilgenthal EM, Schnitzbauer AA, Bechstein WO, Kempf VAJ, et al (2021) Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates. PLoS One 16. https://doi.org/10.1371/journal.pone.0245091 .
Lim YJ, Park HY, Lee JY, Kwak SH, Kim MN, Sung H et al (2018) Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE. Clin Microbiol Infect 24:1104.e5-1104.e8. https://doi.org/10.1016/j.cmi.2018.05.013
doi: 10.1016/j.cmi.2018.05.013
pubmed: 29870856
Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A et al (2012) Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55:905–914. https://doi.org/10.1093/cid/cis580
doi: 10.1093/cid/cis580
pubmed: 22718773
pmcid: 3657523
Giannella M, Trecarichi EM, De Rosa FG, Del Bono V, Bassetti M, Lewis RE et al (2014) Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect 20:1357–1362. https://doi.org/10.1111/1469-0691.12747
doi: 10.1111/1469-0691.12747
pubmed: 24980276
Li B, Zhong Y, Fu XC, Qiu YH, Wang SY, Yang AJ et al (2012) Duration of stool colonization in healthy medical students with extended-spectrum-β-lactamase-producing Escherichia coli. Antimicrob Agents Chemother 56:4558–4559. https://doi.org/10.1128/AAC.00171-12
doi: 10.1128/AAC.00171-12
pubmed: 22687506
pmcid: 3421574
Ling W, Peri AM, Furuya-Kanamori L, Harris PNA, Paterson DL (2022) Carriage duration and household transmission of Enterobacterales producing extended-spectrum beta-lactamase in the community: a systematic review and meta-analysis. Microb Drug Resist 28:795–805. https://doi.org/10.1089/mdr.2022.0035
doi: 10.1089/mdr.2022.0035
pubmed: 35727072
Weterings V, van den Bijllaardt W, Bootsma M, Hendriks Y, Kilsdonk L, Mulders A, et al (2022) Duration of rectal colonization with extended-spectrum beta-lactamase-producing Escherichia coli: results of an open, dynamic cohort study in Dutch nursing home residents (2013–2019). Antimicrob Resist Infect Control 11(1). https://doi.org/10.1186/s13756-022-01132-9 .
Titelman E, Hasan CM, Iversen A, Nauclér P, Kais M, Kalin M et al (2014) Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors. Clin Microbiol Infect 20(8):O508–O515. https://doi.org/10.1111/1469-0691.12559
doi: 10.1111/1469-0691.12559
pubmed: 24450760
Kim YK, Chang IB, Kim HS, Song W, Lee SS (2021) Prolonged carriage of carbapenemase-producing Enterobacteriaceae: clinical risk factors and the influence of carbapenemase and organism types. J Clin Med 10:1–14. https://doi.org/10.3390/jcm10020310
doi: 10.3390/jcm10020310
del Barrio-Tofiño E, López-Causapé C, Oliver A (2020) Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update. Int J Antimicrob Agents 56. https://doi.org/10.1016/j.ijantimicag.2020.106196